Caredx Share Price (NASDAQ: CDNA)

$13.35

▲

0.54

(4.22%)

Live

Last updated on August 28, 2025 at 12:36 am IST

$₹

Check the interactive Caredx Stock chart to analyse performance

Caredx stock performance

as on August 28, 2025 at 12:36 am IST

Today's Low:$12.74
Today's High:$13.35
$13.35
4.57%
Downside
Day's Volatility :4.57%
Upside
0.0%
52 Weeks Low:$10.96
52 Weeks High:$32.97
$13.35
17.9%
Downside
52 Weeks Volatility :66.76%
Upside
59.51%

Caredx Stock Returns

Period	Caredx, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-27.02%	3.7%	0.0%
6 Months	-39.27%	-6.9%	0.0%
1 Year	-59.7%	-11.9%	0.0%
3 Years	-37.12%	7.7%	-6.9%

Caredx, Inc. Key Stats

Check Caredx key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$12.81
Open	$12.645
Today's High	$13.44
Today's Low	$12.74
Market Capitalization	$690.4M
Today's Volume	$1.2M
52 Week High	$32.97
52 Week Low	$10.96
Revenue TTM	$340.8M
EBITDA	$-28.5M
Earnings Per Share (EPS)	$1.05
PE Ratio	12.35
Profit Margin	17.06%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	19.64%

Stock Returns calculator for Caredx Stock including INR - Dollar returns

The Caredx stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Caredx investment value today

Current value as on today

₹46,654

Returns

₹53,346

(-53.35%)

Returns from Caredx Stock

₹58,019 (-58.02%)

Dollar Returns*

₹4,673 (+4.67%)

Indian investors sentiment towards Caredx Stock

-83%

Period: Jul 27, 2025 to Aug 26, 2025. Change in 30 Days versus previous period

Search interest for Caredx Stock from India on INDmoney has decreased by -83% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Caredx, Inc.

Name
Holdings %
Name
Holdings %
BlackRock Inc
9.53%
Vanguard Group Inc
9.23%
Amvescap Plc.
5.01%
State Street Corp
4.67%
BAMCO Inc
4.58%
ARK Investment Management LLC
3.95%

Analyst Recommendation on Caredx Stock

Rating

Trend

Buy

69%Buy

30%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Caredx(by analysts ranked 0 to 5 stars)

Caredx Share Price Target

What analysts predicted

Upside of 66.29%

Target:

$22.20

Current:

$13.35

Caredx share price target is $22.20, a slight Upside of 66.29% compared to current price of $13.35 as per analysts' prediction.

Caredx Stock Insights

Price Movement
In the last 3 months, CDNA stock has moved down by -27.3%
Increasing Revenue
Revenue is up for the last 2 quarters, 84.68M → 86.67M (in $), with an average increase of 2.3% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -10.35M → -8.56M (in $), with an average increase of 20.8% per quarter
CDNA vs IDXX (1 yr)
In the last 1 year, Idexx Laboratories, Inc. has given 33.0% return, outperforming this stock by 92.7%
CDNA vs IDXX (3 yr)
In the last 3 years, Idexx Laboratories, Inc. has given 83.4% return, outperforming this stock by 122.0%
Price to Sales
ForCDNA every $1 of sales, investors are willing to pay $2.0, whereas for Idexx Laboratories, Inc., the investors are paying $12.9 for every $1 of sales.

Caredx, Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$127.1M	↑ 65.95%
Net Income	$-22.0M	↓ 53.02%
Net Profit Margin	-17.29%	↑ 43.77%

	FY20	Y/Y Change
Revenue	$192.2M	↑ 51.25%
Net Income	$-18.7M	↓ 14.81%
Net Profit Margin	-9.74%	↑ 7.55%

	FY21	Y/Y Change
Revenue	$296.4M	↑ 54.22%
Net Income	$-30.7M	↑ 63.85%
Net Profit Margin	-10.34%	↓ 0.6%

	FY22	Y/Y Change
Revenue	$321.8M	↑ 8.57%
Net Income	$-76.6M	↑ 149.86%
Net Profit Margin	-23.81%	↓ 13.47%

	FY23	Y/Y Change
Revenue	$280.3M	↓ 12.89%
Net Income	$-190.3M	↑ 148.37%
Net Profit Margin	-67.88%	↓ 44.07%

	FY24	Y/Y Change
Revenue	$333.8M	↑ 19.07%
Net Income	$52.5M	↓ 127.62%
Net Profit Margin	15.74%	↑ 83.62%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$72.0M	↑ 9.88%
Net Income	$-16.7M	↓ 85.89%
Net Profit Margin	-23.12%	↑ 156.99%

	Q2 FY24	Q/Q Change
Revenue	$92.3M	↑ 28.07%
Net Income	$-1.4M	↓ 91.63%
Net Profit Margin	-1.51%	↑ 21.61%

	Q3 FY24	Q/Q Change
Revenue	$82.9M	↓ 10.18%
Net Income	$-7.4M	↑ 431.42%
Net Profit Margin	-8.94%	↓ 7.43%

	Q4 FY24	Q/Q Change
Revenue	$86.6M	↑ 4.46%
Net Income	$78.0M	↓ 1153.05%
Net Profit Margin	90.1%	↑ 99.04%

	Q1 FY25	Q/Q Change
Revenue	$84.7M	↓ 2.19%
Net Income	$-10.4M	↓ 113.27%
Net Profit Margin	-12.23%	↓ 102.33%

	Q2 FY25	Q/Q Change
Revenue	$86.7M	↑ 2.35%
Net Income	$-8.6M	↓ 17.24%
Net Profit Margin	-9.88%	↑ 2.35%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$81.6M	↑ 87.26%

	FY20	Y/Y Change
Profit	$129.1M	↑ 58.16%

	FY21	Y/Y Change
Profit	$199.0M	↑ 54.18%

	FY22	Y/Y Change
Profit	$209.6M	↑ 5.31%

	FY23	Y/Y Change
Profit	$178.3M	↓ 14.91%

	FY24	Y/Y Change
Profit	$224.2M	↑ 25.7%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$45.5M	↑ 13.83%

	Q2 FY24	Q/Q Change
Profit	$63.7M	↑ 40.06%

	Q3 FY24	Q/Q Change
Profit	$55.3M	↓ 13.17%

	Q4 FY24	Q/Q Change
Profit	$58.4M	↑ 5.59%

	Q1 FY25	Q/Q Change
Profit	$56.3M	↓ 3.65%

	Q2 FY25	Q/Q Change
Profit	$57.4M	↑ 1.96%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-2.8M	↓ 30.9%
Investing Cash Flow	$-22.6M	↑ 184.76%
Financing Cash Flow	$-132.0K	↓ 100.26%

	FY20	Y/Y Change
Operating Cash Flow	$33.4M	↓ 1307.33%
Investing Cash Flow	$-100.4M	↑ 344.63%
Financing Cash Flow	$163.1M	↓ 123697.73%

	FY21	Y/Y Change
Operating Cash Flow	$-19.3M	↓ 157.71%
Investing Cash Flow	$47.7M	↓ 147.52%
Financing Cash Flow	$185.6M	↑ 13.79%

	FY22	Y/Y Change
Operating Cash Flow	$-25.2M	↑ 30.81%
Investing Cash Flow	$-228.5M	↓ 578.92%
Financing Cash Flow	$-4.5M	↓ 102.44%

	FY23	Y/Y Change
Operating Cash Flow	$-18.4M	↓ 27.14%
Investing Cash Flow	$40.4M	↓ 117.7%
Financing Cash Flow	$-29.6M	↑ 552.83%

	FY24	Y/Y Change
Operating Cash Flow	$38.0M	↓ 306.92%
Investing Cash Flow	$-483.0K	↓ 101.19%
Financing Cash Flow	$-5.6M	↓ 81.06%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-15.3M	↑ 82.7%
Investing Cash Flow	$27.7M	↓ 33.14%
Financing Cash Flow	$-1.3M	↓ 95.26%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$18.9M	↓ 223.75%
Investing Cash Flow	$-11.6M	↓ 142.03%
Financing Cash Flow	$-4.9M	↑ 280.39%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$12.5M	↓ 33.92%
Investing Cash Flow	$-14.4M	↑ 23.91%
Financing Cash Flow	$1.4M	↓ 129.32%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$21.9M	↑ 74.8%
Investing Cash Flow	$-2.1M	↓ 85.35%
Financing Cash Flow	$-903.0K	↓ 163.5%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-26.6M	↓ 221.45%
Investing Cash Flow	$1.3M	↓ 162.77%
Financing Cash Flow	$-643.0K	↓ 28.79%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$9.9M	↓ 137.22%
Investing Cash Flow	$23.4M	↑ 1665.81%
Financing Cash Flow	$-53.8M	↑ 8268.74%

Caredx Technicals Summary

Sell

Neutral

Buy

Caredx is currently in a neutral trading position according to technical analysis indicators.

Caredx, Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Caredx, Inc.	0.2%	-39.27%	-59.7%	-37.12%	-62.32%
Agilent Technologies Inc.	-1.05%	-12.03%	-16.17%	-7.67%	18.41%
Idexx Laboratories, Inc.	13.27%	40.16%	32.97%	83.83%	67.11%
Thermo Fisher Scientific, Inc.	0.75%	-8.38%	-19.96%	-12.23%	15.1%
Danaher Corp.	1.65%	-1.5%	-23.26%	-25.44%	0.32%
Iqvia Holdings Inc.	-5.01%	-1.62%	-24.44%	-13.91%	16.52%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Caredx, Inc.	12.35	12.35	-0.12	0.54	0.2	-0.06	NA	6.15
Agilent Technologies Inc.	29.14	29.14	1.75	5.58	0.19	0.08	0.01	21.61
Idexx Laboratories, Inc.	53.4	53.4	4.83	12.6	0.65	0.23	NA	18.2
Thermo Fisher Scientific, Inc.	28.37	28.37	2.04	22.49	0.13	0.05	0.0	133.77
Danaher Corp.	44.2	44.2	2.12	7.77	0.07	0.04	0.01	73.1
Iqvia Holdings Inc.	27.21	27.21	1.08	11.87	0.2	0.05	NA	33.99

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Caredx, Inc.	Buy	$690.4M	-62.32%	12.35	17.06%
Agilent Technologies Inc.	Buy	$33.6B	18.41%	29.14	17.59%
Idexx Laboratories, Inc.	Buy	$51.3B	67.11%	53.4	24.41%
Thermo Fisher Scientific, Inc.	Buy	$185.3B	15.1%	28.37	15.24%
Danaher Corp.	Buy	$148.7B	0.32%	44.2	14.21%
Iqvia Holdings Inc.	Buy	$31.9B	16.52%	27.21	7.88%

About Caredx, Inc.

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI, a transplant quality tracking software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.

Organization	Caredx
Employees	644
CEO	Mr. John Walter Hanna Jr.
Industry	Health Technology

Key Management of Caredx, Inc.

Name	Title
Mr. John Walter Hanna Jr.	President, CEO & Director
Mr. Keith S. Kennedy C.F.A., CPA	Chief Operating Officer
Mr. Jeffrey A. Novack	General Counsel & Secretary
Ms. Jessica Meng	Chief Commercial Officer
Mr. Nathan A. Smith	Chief Financial Officer
Mr. Kashif Rathore	Chief Technology Officer
Dr. Robert N. Woodward Ph.D.	Chief Scientific Officer
Ms. Marica Grskovic Ph.D.	Chief Strategy Officer
Ms. Jing Huang Ph.D.	Chief Data & Artificial Intelligence Officer
Ms. Jennifer Foley	Chief Product Officer

Important FAQs about investing in CDNA Stock from India :

What is Caredx share price today?

Caredx share price today is $13.35 as on August 28, 2025 at 12:36 am IST. Caredx share today touched a day high of $13.35 and a low of $12.74.

What is the 52 week high and 52 week low for Caredx share?

Caredx share touched a 52 week high of $32.97 and a 52 week low of $10.96. Caredx stock price today i.e. August 28, 2025 at 12:36 am IST is trending at $13.35, lower by 59.51% versus the 52 week high.

How to invest in Caredx Stock (CDNA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Caredx on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Caredx Shares that will get you 0.1124 shares as per Caredx share price of $13.35 per share as on August 28, 2025 at 12:36 am IST.

What is the minimum amount required to buy Caredx Stock (CDNA) from India?

Indian investors can start investing in Caredx (CDNA) shares with as little as ₹87.86 or $1 (as of August 27, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹878.60 in Caredx stock (as per the Rupee-Dollar exchange rate as on August 27, 2025). Based on Caredx share’s latest price of $13.35 as on August 28, 2025 at 12:36 am IST, you will get 0.7491 shares of Caredx. Learn more about fractional shares .

What are the returns that Caredx has given to Indian investors in the last 5 years?

Caredx stock has given -62.32% share price returns and 18.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?